Stock AEON AEON BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AEON Biopharma, Inc.

Equities

AEON

US00791X1000

Real-time Estimate Cboe BZX
Other stock markets
 10:40:11 2024-06-27 EDT 		5-day change 1st Jan Change
1.075 USD +6.44% Intraday chart for AEON Biopharma, Inc. -15.75% -85.14%
05-16 AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 CI
05-16 AEON Biopharma, Inc. Announces Executive Changes CI

Evolution of the average Target Price on AEON Biopharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

94e5bc81c9e31.jIsBgctyhftB5uB3mNvvDO2WpKyqx71QGpu5ARYnsKI.__5i6oUw8YsPpacv7qjCIdry0Nzipog1c6LLNWwf_prbvHbtqAXJlzWU0A~104426da9166ba85b7d1bbf96d65f9dd

Analyst Recommendations on AEON Biopharma, Inc.

HC Wainwright Starts AEON Biopharma at Buy With $18 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.01 USD
Average target price
6 USD
Spread / Average Target
+494.06%
High Price Target
6 USD
Spread / Highest target
+494.06%
Low Price Target
6 USD
Spread / Lowest Target
+494.06%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AEON Biopharma, Inc.

HC Wainwright

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AEON Stock
  4. Consensus AEON Biopharma, Inc.